Cocrystal Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2007
Net Income	-17.98	-38.84	-14.19	-9.65	-48.17	-49.05	-0.61	-74.87	-50.12	-0.1	Upgrade
Depreciation & Amortization	0.19	0.19	0.19	0.34	0.25	0.05	0.1	0.2	0.19	0.2	Upgrade
Share-Based Compensation	0.8	0.86	0.72	0.66	0.35	0.56	0.61	0.55	2.93	0.04	Upgrade
Other Operating Activities	2.33	16.36	0.55	-1.18	46	40.15	-7.01	59.47	36.68	-6.15	Upgrade
Operating Cash Flow	-14.67	-21.44	-12.72	-9.83	-1.56	-8.29	-6.9	-14.66	-10.32	-6.01	Upgrade
Capital Expenditures	-0.12	-0.07	-0.05	-0.24	-0.15	-0.03	-0.04	-0.05	-0.34	-0.01	Upgrade
Acquisitions	0	0	0	0	0	0	0	0	0	0.78	Upgrade
Change in Investments	0	0	0	0	0	1.4	0	0.05	0.08	5.3	Upgrade
Investing Cash Flow	-0.12	-0.07	-0.05	-0.24	-0.15	1.37	-0.04	0	-0.26	6.08	Upgrade
Share Issuance / Repurchase	4	0	38.51	35.78	6.64	7.91	3.08	9.02	15.89	2.87	Upgrade
Debt Issued / Paid	-0.01	-0.03	-0.04	-0.12	-0.21	0.98	1	0	0	0	Upgrade
Financing Cash Flow	3.99	-0.03	38.47	35.66	6.42	8.89	4.08	9.02	15.89	2.87	Upgrade
Net Cash Flow	-10.79	-21.54	25.7	25.59	4.72	1.98	-2.86	-5.64	5.31	2.94	Upgrade
Free Cash Flow	-14.78	-21.51	-12.77	-10.07	-1.71	-8.32	-6.94	-14.71	-10.66	-6.02	Upgrade
Free Cash Flow Margin	-	-	-	-500.00%	-26.02%	-	-	-	-13661.54%	-66855.56%	Upgrade
Free Cash Flow Per Share	-1.53	-2.64	-1.73	-2.19	-0.64	-3.56	-3.45	-7.50	-6.09	-6.63	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).